HDAC9 and retinitis pigmentosa: Excessive HDAC activation plays a critical role in neurodegeneration in a mouse model of retinitis pigmentosa (Sancho-Pelluz et al., 2010), and several HDAC inhibitors have neuroprotective effects in retinal degenerative diseases (reviewed in Zhang et al., 2015).